Clinical Research Study for Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT)
We will soon begin to enroll participants in the GLR305-E001 study, which is testing an investigational eye drop (a ROCK inhibitor, similar to Rhopressa®) as a potential new treatment for people with Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT).
About the Study
- The study will last about 30 days.
- The investigational treatment is designed to help lower eye pressure.
Who Can Join?
This study may be a fit if you:
- Are 18 years of age or older
- Have a diagnosis of OAG or OHT
- Have an unmedicated eye pressure (IOP) between 24–36 mmHg
Why Participate?
By joining, you may gain access to an investigational treatment option while also helping advance research that could improve care for people living with glaucoma or ocular hypertension.
If you or someone you know has been diagnosed with OAG or OHT and would like more information, please contact our research team to see if you qualify.
Interested? Contact Our Research Team
Glaucoma and Ocular Hypertension
-
Stent for the treatment of Primary Open Angle Glaucoma at the time of cataract surgery
Study description on clinicaltrials.gov
Diabetic Retinopathy
-
Oral medication for patients with moderate to severe Diabetic Retinopathy.
Study description on clinicaltrials.gov
Age Related Macular Degeneration
- Epidemiological study of AMD progression (non-interventional)
Pediatric
-
Dextenza for Inflammation and Pain Following Surgery for Pediatric Cataract.
Study description on clinicaltrials.gov
Past Clinical Trials
Eye Center of Northern Colorado is privileged to have worked with many drugs and devices that went on to gain FDA approval and are now used to treat patients every day. Some of these technologies include:
Cataract
- Acrysof Restor IOL
- Acrysof High Toric IOL
- IQ Vivity IOL
- IC-8 IOL
Glaucoma
- Glaukos iStent
- Xen Shunt
- Glaukos iStent Inject
- Glaukos G2-W
- Hydrus Microstent
- Rhopressa
- Simbrinza
- Glaukos iDose TR
- Elios System to Reduce Intraocular Pressure in Combination with Cataract Surgery
Myopia
- Pediatric Myopia Ophthalmic Solution SYD-101
- Progression of Myopia in Pediatric Patients using Atropine Sulphate 0.01% (OT-101)
Presbyopia
- Kamra Inlay
Retina
- Susvimo for Wet Age-related Macular Degeneration
- Diabetic Retinopathy OPL-0401
- Macular Edima Port Delivery System with Lucentis (Pagoda)
- Wet AMD Port Delivery System with Lucentis (Portal)
Dry Eye
- Tyrvaya Nasal Spray
Keratoconus
- Oxygen Enriched Cross-Linking
Inflammation
- Inveltys
- TobraDex
- Nevanac
